Still no smoking gun
- 07 June 2021 (5 min read)
Key points:
- More signs of supply-side tension on the US labor market, but still no sense of a permanent shift.
- The ECB will need to choose its words carefully on Thursday. Optimism on the reopening needs to be tempered while the latest pandemic developments in the UK are being assessed.
- The G7 agreement on global corporate taxation is another blow to the already ailing “Washington consensus”
More signals of supply-side tension in the US have emerged with the release of the labor market data for May. We focus on the strong rebound in the relative pay of low-skilled workers in the hospitality sector which is taking place even though the number of jobs of this type is still more than 15% below the pre-pandemic level. This would suggest that employers are consenting to significant pay rises to lure employees back. There is no clearer indication than last month on which explanation – childcare issues or over-generous unemployment benefits – dominates, and we may never know since those hurdles are likely to fade broadly at the same time. The ongoing reopening of the US is extending to schools, while nearly half of the states have decided to terminate the federal top-up of unemployment benefits ahead of schedule, in general by July (it could have continued until November). In any case, since those factors are both transitory, as such they cannot sway the Fed in one direction or another.
The ECB has communicated profusely ahead of its Governing Council this Thursday, which should insure us against anything revolutionary. Still, they will have to choose their words wisely to qualify the pace at which PEPP is continuing. We continue to think they will abstain from any significant rhetorical shift this time, waiting to see how the reopening of the European economy is shaping up. The Governing Council is probably taking a hard look at the latest pandemic developments in the UK. The rebound in hospitalizations is still very tentative over there, but it is already a reminder of a very simple truth: with aggressive variants, the threshold for collective immunity rises. Although the UK is among the most advanced countries on vaccination, there is still a “reservoir” of more than 4 million people above the age of 50 who have not been fully protected. This still leaves open the possibility to see more pressure building on the healthcare system.
The G7 agreed over the weekend on the “two pillars” of the strategy laid out by the OECD on global corporate taxation. It will still take a lot of work before any decision is implemented. Still, at this stage we can already add this piece of news to our already long obituary of the “Washington consensus”.
Not for Retail distribution
This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.
This promotional communication does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee that forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.
Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document / scheme documents, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for professional external advice.
The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.
Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.